Literature DB >> 23662995

Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol.

C K Ahogo1, K Ezzedine, S Prey, V Colona, A Diallo, F Boralevi, A Taïeb, C Léauté-Labrèze.   

Abstract

BACKGROUND: Although propranolol has become the first-line therapy for infantile haemangiomas (IHs), no study has yet investigated factors associated with the risk of relapse in children with IH treated with propranolol after cessation of treatment.
OBJECTIVES: To compare factors associated with the risk of relapse in children with IH treated with oral propranolol.
METHODS: We conducted a single-centre retrospective observational study. All files and photographs of patients with IH aged 5 months or less at the time of treatment initiation, and who were seen between 1 June 2008 and 31 December 2011 at the National Reference Center for rare skin diseases of Bordeaux, were retrospectively reviewed.
RESULTS: In total 158 children were included, of whom 118 had not relapsed and 40 had relapsed. Fifty-two patients were boys and 106 were girls (male : female ratio 1 : 2), and 19 had a segmental IH (12%). When conducting multivariate analysis, only IHs with a deep component and those with segmental distribution were independently associated with relapse.
CONCLUSIONS: Our study shows that segmental IHs, as well as haemangiomas with a deeper component, are more at risk of relapse and should thus indicate closer follow-up after treatment interruption, and/or longer treatment.
© 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23662995     DOI: 10.1111/bjd.12432

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

Review 1.  Treatment of infantile haemangiomas: recommendations of a European expert group.

Authors:  Peter H Hoeger; John I Harper; Eulalia Baselga; Damien Bonnet; Laurence M Boon; Marta Ciofi Degli Atti; Maya El Hachem; Arnold P Oranje; Agneta Troilius Rubin; Lisa Weibel; Christine Léauté-Labrèze
Journal:  Eur J Pediatr       Date:  2015-05-29       Impact factor: 3.183

2.  Infantile Periocular Haemangioma: Optimising the Therapeutic Response.

Authors:  Robert H Taylor
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

Review 3.  PHACE syndrome: clinical manifestations, diagnostic criteria, and management.

Authors:  Anita Rotter; Luciana Paula Samorano; Maria Cecília Rivitti-Machado; Zilda Najjar Prado Oliveira; Bernardo Gontijo
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

4.  EFFECTIVENESS OF FIXED DOSES OF PROPRANOLOL IN THE TREATMENT OF HEMANGIOMAS REGARDLESS OF CHILD'S WEIGHT GAIN: A CASE REPORT.

Authors:  Jaime Anger; Eduardo Mesquita de Oliveira; José Gabel
Journal:  Rev Paul Pediatr       Date:  2019-05-09

5.  Propranolol induces hemangioma endothelial cell apoptosis via a p53‑BAX mediated pathway.

Authors:  Tian-Hua Yao; Parekejiang Pataer; Krishna Prasad Regmi; Xi-Wen Gu; Quan-Yan Li; Jing-Ting Du; Su-Meng Ge; Jun-Bo Tu
Journal:  Mol Med Rep       Date:  2018-05-14       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.